Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists
Patent 6221887 Issued on April 24, 2001. Estimated Expiration Date: 
September 13, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 13, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesCertain tetrahydrocannabinol-7-oic acid derivatives (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them Patent #: 5635530 InventorsAssigneeApplicationNo. 380988 filed on 09/13/1999US Classes:514/357, Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding514/626, Nitrogen in R514/649Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chainExaminersPrimary: Jarvis, William R. A.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/44A61K 031/16 A61K 031/135 Foreign Application Priority Data1998-04-28 SEAbstractThe invention relates to the use of certain pharmaceutical compounds as anti-inflammatory agents. | |
